Savyon Diagnostics, Ltd.

Contact: Esti Sagiv
Web: http://www.savyondiagnostics.com
Address: 3 Habosem St., Ashdod 77610, Israel
Phone: +972-(8)-8562920 | Fax: +972-(8)-8523176 | Map/Directions >>

Profile: Savyon Diagnostics, Ltd. develops, manufactures and markets diagnostic kits for the detection of infectious diseases. Our products are categorized according to disease diagnosis areas such as sexually transmitted diseases, respiratory tract infections, urinary tract infections and rapid tests. The tests are based on various immunological techniques (ELISA, MIF, IPA, rapid single tests). Our SeroCP™ is an Elisa based test for specific & sensitive qualitative detection of chlamydia pneumoniae IgM, IgG and IgA antibodies. The assay uses purified elementary bodies of C.pneumoniae (TWAR-183) as antigens to detect the antibody response. SeroCP™ is the perfect screening tool for the detection of C.pneumoniae antibodies in human serum. It is a second generation assay for the semi-quantitative determination of chlamydia pneumoniae IgG and IgA antibodies. The assay utilizes 3 calibrators such as P10, P50 and P100 that are included in the kit, to create a standard curve. By using the standard curve, samples absorbance value in O.D are interpreted to concentration in BU/ml unit. The interpolated BU/ml units can be converted into SeroFIA™-MIF end point titer, by using the package insert conversion table. The assay protocol & use of standard curve enables defining the kinetics of IgG and IgA antibodies in paired sera thus leading to improved diagnostic value.

The company was founded in 2001 and is ISO 13485:2003 and ISO 13485:1996, CE certified.

FDA Registration Number: 8030124
US Agent: Zohar Shipony
Phone: +1-(408)-830-4534 E-Mail:

8 Products/Services (Click for related suppliers)

• Chlamydia Group Enzyme Linked Immunoabsorbent Assay (FDA Code: LJC / 866.3120)

Chlamydia serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to chlamydia in serum. Additionally, some of these reagents consist of chlamydia antisera conjugated with a fluorescent dye used to identify chlamydia directly from clinical specimens or cultured isolates derived from clinical specimens. The identification aids in the diagnosis of disease caused by bacteria belonging to the genusChlamydia and provides epidemiological information on these diseases. Chlamydia are the causative agents of psittacosis (a form of pneumonia), lymphogranuloma venereum (a venereal disease), and trachoma (a chronic disease of the eye and eyelid).

• Chlamydia Spp. Immunoperoxidase Antisera (FDA Code: LKH / 866.3120)

• Fluorescent B. Pertussis Antisera (FDA Code: GOZ / 866.3065)

• HCG Over The Counter Pregnancy Test Kit (FDA Code: LCX / 862.1155)

A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.

• Id Direct Antigen Candida Spp. (FDA Code: LRF / 866.3165)

• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485)

A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.

• Mycoplasma Spp Enzyme Linked Immunoabsorbent Assay (FDA Code: LJZ / 866.3375)

• Urine Screening Kit (FDA Code: JXA / 866.2660)

A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease.